Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 4Neoplasms 3Cardiovascular Diseases 2Urogenital Neoplasms 1Smoldering Multiple Myeloma 1Sarcoma 1Psoriasis 1Prostatic Neoplasms 1Precancerous Conditions 1Pain 1Osteoarthritis 1Monoclonal Gammopathy of Undetermined Significance 1Melanoma 1Lung Neoplasms 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hypertension 1Head and Neck Neoplasms 1Fatigue 1Diabetes Mellitus 1Depressive Disorder, Major 1Depression 1Colorectal Neoplasms 1Carcinoma, Intraductal, Noninfiltrating 1Breast Neoplasms, Male 1Breast Carcinoma In Situ 1Autoimmune Diseases 1Arthritis, Rheumatoid 1Arthralgia 1

Interventions

Tamoxifen 6Radiotherapy 3Anastrozole 3Taxes 2Simvastatin 2Radiation 2Paclitaxel 2Neoadjuvant Therapy 2Letrozole 2Gene Expression Profiling 2Chemotherapy, Adjuvant 2Celecoxib 2telapristone acetate 1poly(I).poly(c12,U) 1oxybutynin 1liposomal doxorubicin 1exemestane 1dexamethasone acetate 1dexamethasone 21-phosphate 1auricularum 1Yoga 1Sugars 1Sentinel Lymph Node Biopsy 1Ranitidine 1Radiation Dose Hypofractionation 1Pharmacogenomic Testing 1Naltrexone 1Monitoring, Physiologic 1Mometasone Furoate 1Metformin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Breast Carcinoma In Situ × Fatty Acids, Omega-3 × Clear all
NCT01869764 2019-10-30

Omega-3 Fatty Acid in Treating Patients With Stage I-III Breast Cancer

Wake Forest University Health Sciences

Phase 2 Completed
57 enrolled 8 charts
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon âš¡